CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-10 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Shares withheld for taxes | −13,898 | $106.46 | $1.5M | 237,747 |
| 2020-03-10 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +100 | $71.17 | $7K | 237,847 |
| 2020-03-10 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −100 | $112.19 | $11K | 237,747 |
| 2020-03-10 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −100 | $71.17 | $7K | 11,717 |
| 2020-03-10 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +837 | $106.46 | $89K | 25,253 |
| 2020-03-10 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −277 | $106.46 | $29K | 24,977 |
| 2020-03-10 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award | +5,018 | $106.46 | $534K | 29,907 |
| 2020-03-10 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −2,517 | $106.46 | $268K | 27,390 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +230,178 | $71.17 | $16.4M | 456,738 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −171,025 | $112.21 | $19.2M | 285,713 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −36,790 | $113.65 | $4.2M | 248,923 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −16,426 | $114.24 | $1.9M | 232,497 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −3,937 | $115.45 | $455K | 228,560 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −2,000 | $116.27 | $233K | 226,560 |
| 2020-03-06 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −230,178 | $71.17 | $16.4M | 11,817 |
| 2020-02-27 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −690 | $109.02 | $75K | 40,087 |
| 2020-02-27 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −789 | $109.02 | $86K | 68,411 |
| 2020-02-27 | Davis J. E. EVP, General Diagnostics | Sale | −1,100 | $109.02 | $120K | 38,105 |
| 2020-02-26 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −321 | $111.09 | $36K | 41,445 |
| 2020-02-26 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −668 | $112.90 | $75K | 40,777 |
Page 43 of 52 · 1,040 trades